Novel technologies in human reproduction
Precongress Course 13
Special Interest Group Stem Cells
Course type
Basic
Course co-ordinator
Susana M. Chuva de Sousa Lopes (The Netherlands)
Course description
This Precongress Course will focus on several innovative novel technologies that are changing the landscape of the tools available to perform in vitro modelling on relevant aspects of human reproduction and fertility. We will compare the use of mesenchymal stem cell versus pluripotent stem cells in human reproduction and provide an update on the current use of human embryonic stem cells in the Europe. The scientific topics to be discussed include updates on gene-editing in human embryos, advances in human embryo-like structures, microfluidics in devising artificial ovaries and how single-cell sequencing is contributing to a cell atlas of the ovary.
Target audience
Embryologists, stem cell researchers, reproductive genetic researchers, clinicians
Educational needs and expected outcomes
This course will:
- review future how novel technologies could impact human reproduction
- discuss the use of mesenchymal stem cells and pluripotent stem cells
- debate recent breakthroughs of artificial ovaries and human reproductive organs, gene editing in human embryos and human embryo-like structures
Programme
Saturday 26 June 2021
09:00 - 12:30
PCC13: Novel technologies in human reproduction - part 1
Saturday 26 June 2021
09:00 - 12:30: PCC13: Novel technologies in human reproduction - part 1:
Download Q&A here
Susana M. Chuva de Sousa Lopes, The Netherlands
09:00 - 09:30
New insights to early development and cellular reprogramming
09:45 - 10:15
Bioinformatics to determine gene variants implicated in disorders of sexual development
Daniel Rodriguez Gutiérrez, Switzerland
10:30 - 11:00
Coffee break
Christiani Amorim, Belgium
Jasin Taelman, The Netherlands
11:00 - 11:30
Divergent ESC policies in Europe: overview & practical difficulties for international collaboration
11:45 - 12:15
What stem cells will prove more efficient in the future: Mesenchymal vs Pluripotent?
Cristina Eguizabal, Spain
12:30 - 13:30
Lunch break